CD4 and HIV infectious disease: These findings indicate that MPA selectively impacts endometrial CD4+ T cells in a way that is opposite to that seen with blood CD4+ T cells both in terms of TFV and TAF protection against HIV infection and intracellular TFV-DP concentrations.